InsiderTrades

Form 4 for CRTO Criteo S.A.

Accepted 2021-12-20 00:00:00 ET · period of report 2021-12-16 · accession 0001576427-21-000084 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
DM 2021-12-20 2021-12-16 CRTO Damon Ryan EVP, Gen Counsel, Sec S - Sale+OE $41.01 -10.8K 118.4K -8% -$441.4K
D 2021-12-20 2021-12-16 CRTO Damon Ryan EVP, Gen Counsel, Sec M - OptEx $41.01 +7,717 126.1K +7% +$316.5K
D 2021-12-20 2021-12-16 CRTO Damon Ryan EVP, Gen Counsel, Sec M - OptEx $0.00 -7,717 16.8K -31% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Ordinary Shares 2021-12-16 S D 7,717 $41.01 118,432 D — — (F1) The Ordinary Shares may be represented by American Depository Shares, each of which represents One Ordinary Share. (F3) For more information about the equity of the issuer held by the reporting person, please see the issuer's most recent definitive proxy statement filed with the Securities and Exchange Commission.
2 Common Ordinary Shares 2021-12-16 M A 7,717 $41.01 126,149 D — — (F1) The Ordinary Shares may be represented by American Depository Shares, each of which represents One Ordinary Share. (F3) For more information about the equity of the issuer held by the reporting person, please see the issuer's most recent definitive proxy statement filed with the Securities and Exchange Commission.
3 Common Ordinary Shares 2021-12-16 S D 3,046 $41.00 118,432 D — — (F1) The Ordinary Shares may be represented by American Depository Shares, each of which represents One Ordinary Share. (F2) The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $41.00 to $41.03, inclusive. The reporting person undertakes to provide to any security holder of Criteo S.A. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. (F3) For more information about the equity of the issuer held by the reporting person, please see the issuer's most recent definitive proxy statement filed with the Securities and Exchange Commission.
4 Derivative Stock Option (right to buy) 2021-12-16 M D 7,717 $0.00 16,845 D $21.10 · — to 2028-10-25 7,717 Ordinary Shares (F4) Stock options granted on October 25, 2018. One-fourth of the grant vests on the first anniversary of the grant date and additional 1/16th of the grant vests quarterly thereafter for a period of 36 months, subject to continued service through each vesting date.